Amine-Linked Flavonoids as Agents Against Cutaneous Leishmaniasis

Area of Science:

• Medicinal Chemistry
• Parasitology
• Tropical Diseases

Background:

• Cutaneous leishmaniasis is a tropical disease affecting 80 countries.
• Existing treatments for leishmaniasis have limitations.
• Flavonoid compounds are being explored for therapeutic potential.

Purpose of the Study:

• To design, synthesize, and characterize novel amine-linked flavonoid compounds.
• To evaluate the in vitro and in vivo efficacy of these compounds against Leishmania parasites.
• To identify a potent and metabolically stable candidate for leishmaniasis treatment.

Main Methods:

• Synthesis and characterization of 38 novel amine-linked flavonoids.
• In vitro testing against Leishmania amastigotes (IC50 determination).
• Metabolic stability assays using liver microsomes.
• In vivo efficacy study in a Leishmania amazonensis mouse model.

Main Results:

• Several compounds showed potent in vitro activity against Leishmania parasites.
• FM09h demonstrated high activity (IC50 = 0.3 μM) against L. amazonensis, L. tropica, and L. braziliensis.
• FM09h exhibited good metabolic stability.
• Intralesional injection of FM09h significantly reduced lesion thickness in mice (72% reduction), comparable to SSG (63%).

Conclusions:

• Amine-linked flavonoids represent a promising class of compounds for leishmaniasis treatment.
• FM09h is a potent and effective candidate, showing significant efficacy in a preclinical mouse model.
• Further development of FM09h could lead to a new therapeutic option for cutaneous leishmaniasis.